14 November 2023 - The utilisation analysis public release documents from the June 2023 DUSC meeting are now available. ...
13 November 2023 - The Outcome Statement from the September 2023 DUSC meeting is now available. ...
20 July 2023 - The utilisation analysis public release documents from the February 2023 DUSC meeting are now available. ...
18 July 2023 - The outcome statement from the June 2023 DUSC meeting is now available. ...
12 April 2023 - Given the current market dynamics and the regulatory landscape, this ASCO manuscript now seeks to propose several ...
31 March 2023 - The outcome statement from the February 2023 DUSC meeting is now available. ...
22 December 2022 - The explosion in popularity of the drugs comes despite warnings from psychiatrists that antidepressants should not be ...
3 November 2022 - The outcome statement from the September 2022 DUSC meeting is now available. ...
25 October 2022 - The utilisation analysis public release documents from the June 2022 DUSC meeting are now available. ...
21 October 2022 - Saskatchewan joined five provinces and one territory in implementing a biosimilar switching policy, allowing for reference ...
12 October 2022 - Ninth Edition of Amgen's Biosimilar Trends Report Examines the U.S. and Global Marketplace with Biosimilars. ...
3 October 2022 - The Dental and Pharmaceutical Benefits Agency (TLV) is today handing over a report to the government on ...
25 September 2022 - Novavax was hailed as the fix to Australia’s low inoculation rate and “the vaccine for anti-vaxxers”. So ...
21 September 2022 - Novavax COVID vaccines procured by the federal government in the hopes of convincing hesitant Australians to ...
30 August 2022 - Key findings about health and population characteristics from the National Health Survey (NHS) and the Pharmaceutical Benefits ...